Neurological sequelae of cancer immunotherapies and targeted therapies.

Wick, Wolfgang; Hertenstein, Anne; Platten, Michael

Wick, Wolfgang; Hertenstein, Anne; Platten, Michael.

Afiliação

Wick W; Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Units, Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: wolfgang.wick@med.uni-heidelberg.de.
Hertenstein A; Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany; Clinical Cooperation Units, Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
Platten M; Department of Neurology and Neurooncology Program, National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany; Brain Tumor Immunology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Lancet Oncol ; 17(12): e529-e541, 2016 Dec.

Article em En | MEDLINE | ID: mdl-27924751

Assuntos

Imunoterapia/efeitos adversos; Terapia de Alvo Molecular/efeitos adversos; Neoplasias/terapia; Doenças do Sistema Nervoso/etiologia; Encefalopatias/etiologia; Doenças Cerebelares/etiologia; Humanos; Leucoencefalopatias/etiologia; Convulsões/etiologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Terapia de Alvo Molecular / Imunoterapia / Neoplasias / Doenças do Sistema Nervoso Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google